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Background: Breast cancer survivors, particularly those treated with chemotherapy, are at significantly increased risk
for long-term cognitive and neurobiologic impairments. These deficits tend to involve skills that are subserved by
distributed brain networks. Additionally, neuroimaging studies have shown a diffuse pattern of brain structure
changes in chemotherapy-treated breast cancer survivors that might impact large-scale brain networks.
Methods: We therefore applied graph theoretical analysis to compare the gray matter structural networks of
female breast cancer survivors with a history of chemotherapy treatment and healthy age and education matched
female controls.
Results: Results revealed reduced clustering coefficient and small-world index in the brain network of the breast
cancer patients across a range of network densities. In addition, the network of the breast cancer group had less
highly interactive nodes and reduced degree/centrality in the frontotemporal regions compared to controls, which
may help explain the common impairments of memory and executive functioning among these patients.
Conclusions: These results suggest that breast cancer and chemotherapy may decrease regional connectivity as
well as global network organization and integration, reducing efficiency of the network. To our knowledge, this is
the first report of altered large-scale brain networks associated with breast cancer and chemotherapy.Background
Breast cancer is one of the most frequently diagnosed
cancers and the leading cause of cancer death among
females, accounting for 23% of the total cancer cases [1].
In the last decade, several neuropsychological studies
have shown the negative influence of breast cancer and
chemotherapy on various cognitive skills with executive
function and memory impairments being the most com-
mon [2,3]. These deficits have been reported both prior
and following chemotherapy with evidence showing
increased and/or more severe cognitive changes in
breast cancer patients treated with chemotherapy [4-9].
Neuroimaging studies corroborate these findings by
showing changes in both brain structure and function
associated with breast cancer and chemotherapy [10].
However, it is currently unknown whether breast cancer
and chemotherapy affect large-scale brain networks.* Correspondence: skesler@stanford.edu
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reproduction in any medium, provided the orThere are several lines of evidence suggesting that
breast cancer may negatively impact whole brain net-
works. First, while the mechanisms by which breast can-
cer and its treatments affect cognitive function are
largely unknown, possible candidates include neurotoxic
effects of chemotherapy, oxidative damage, cytokine dys-
regulation and individual variation in genes related to
neural repair and/or plasticity [2,3,11,12]. These candi-
date mechanisms are likely to have diffuse effects on
brain structure. Second, neuroimaging studies indicate
that breast cancer survivors show altered brain structure,
which would disrupt large-scale networks [13]. Specific-
ally, these patients demonstrate reduced gray matter in
bilateral frontal, temporal, cerebellar, thalamic, and cin-
gulate regions as well as decreased white matter integrity
in corpus callosum, frontal, and temporal white matter
tracts [14-17]. Third, the specific cognitive domains that
tend to be most commonly impaired in breast cancer in-
volve executive functions and memory, as noted above.
These skills are known to be subserved by distributed,
integrated neural networks [18]. Finally, cognitive im-
pairment following breast cancer often tends to be quitel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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jury. In the current study, we investigated whether
breast cancer and chemotherapy are associated with
alterations in large-scale structural brain networks.
Recent graph-theoretical analyses have consistently
shown that brain structural networks in healthy indivi-
duals have small-world characteristics [19]; an architec-
ture that has dense local clustering of connections
between neighboring nodes with short path length be-
tween any pair of nodes due to the existence of relatively
few long-range connections [20]. These characteristics,
shared by various biological systems, reflect a network
that is simultaneously highly segregated and integrated
and allows for higher, more efficient rates of information
processing and learning than random networks [21].
Since small-world characteristics were described quan-
titatively for brain structural networks, there have been
multiple graph-theoretical studies seeking to assess the
structural correlation networks constructed from regional
gray matter volume, cortical thickness and surface area
[12,20,22,23]. The unique feature of graph-theoretical
analysis, compared with the more traditional univariate
neuroimaging approaches, is that it can directly test the
differences in topological parameters of the brain net-
work such as small-worldness, highly connected hubs
and regional network parameters. Whereas univariate
neuroimaging approaches have typically shown limited
correlations with cognitive function and dysfunction, net-
work parameters may provide a more robust model of
cognitive status [24,25]. Recent graph-theoretical studies
have illustrated an alteration of arrangements in struc-
tural correlation networks associated with normal aging,
multiple sclerosis, Alzheimer’s disease, schizophrenia and
epilepsy [26-30].
In the present study, we applied graph theoretical ana-
lyses to compare magnetic resonance imaging (MRI)-
based gray matter correlation networks of female breast
cancer patients treated with chemotherapy and female
healthy controls. Considering the lines of evidence
regarding a diffuse pattern of gray matter atrophy in
breast cancer patients, we hypothesized that such altera-
tions should be reflected in small-world characteristics






premorbid cognitive status* 13.0 (6.0)
*measured using the Information subtest of the Wechsler Adult Intelligence Scale 4
Data are shown as mean (standard deviation) except where noted.examined the between group differences in highly con-
nected hubs as well as in regional network measures
such as node betweenness and degree.Methods
Participants
Thirty-seven female primary breast cancer survivors
(BC) age 43-67 years who were treated with systemic
chemotherapy (mean time since treatment = 4.5 ± 3.4
years) and 38 age-matched healthy controls (CON) par-
ticipated in the study. BC survivors were recruited via
the Army of Women (http://www.armyofwomen.org/),
community-based BC support groups and local media
advertisements. Healthy controls were recruited via the
Army of Women and local media advertisements.
Groups were matched for age, education, premorbid
cognitive functioning and minority status although there
were significantly more post-menopausal women in the
BC group (Table 1). Premorbid cognitive functioning
was measured using the Information subtest of the
Wechsler Adult Intelligence Scale 4th Edition. This subt-
est measures fund of general knowledge and is believed
to be influenced by previous experience and quality of
education, making it a good estimate of premorbid abil-
ity [31]. Participants in the BC group were free from dis-
ease and had no history of relapse or recurrence at the
time of evaluation. Chemotherapy regimens included
AC (Doxorubicin, Cyclophosphamide) (N= 9), ACT
(Doxorubicin, Cyclophosphamide, Paclitaxel) (N= 16),
ACF (Doxorubicin, Cyclophosphamide, 5-Fluorouracil)
(N= 2), CT (Cyclophosphamide, Paclitaxel) (N = 6), CMF
(Cyclophosphamide, Methotrexate, 5-Fluorouracil)
(N= 2), CTF (Cyclophosphamide, Paclitaxel, 5-Fluorour-
acil) (N = 1) and AC+CMF (N= 1). Additionally, 15
women were treated with tamoxifen and 25 received ra-
diation therapy. None of the BC patients had cerebral
metastasis or had been treated for that. Participants were
excluded for neurologic, psychiatric or medical condi-
tions known to affect cognitive function (e.g. learning
disability, traumatic brain injury, chronic depression) as
well as any MRI contraindications (e.g. non-MRI safe
implants). This study was approved by the Stanfordcontrol groups
CON (N=38) t or Chi Sq. p-value
55.5 (9.0) .737 .46
17 (2.6) 1.61 .11
10.5% 2.27 .69
55.9% 7.24 .007
13.8 (2.7) .774 .44
th Edition.
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pants provided informed consent.
MRI data acquisition and preprocessing
MRI scanning was performed on a GE Discovery MR750
3.0 Tesla whole body scanner (GE Medical Systems, Mil-
waukee, WI). High-resolution T1-weighted images were
acquired with 3D spoiled gradient echo pulse sequence
using the following parameters: TR = 8.5 ms, TE = 3.396,
TI = 400 ms, flip angle = 15, FOV= 220 mm, number of
excitation =1, acquisition matrix = 256 x 192. Totally,
124 contiguous coronal slices were with in-plane reso-
lution of 0.859 mm x 0.859 mm.
Image preprocessing was performed using Statistical
Parametric Mapping 8 (SPM8; Wellcome Department of
Cognitive Neurology, London, UK; http://www.fil.ion.
ucl.ac.uk/spm/). The images were initially segmented
into gray matter (GM), white matter, and cerebrospinal
fluid images based on the ICBM Tissue Probabilistic
Maps (http://www.loni.ucla.edu/ICBM/ICBM Tissue-
Prob.html). A study-specific a priori probability map of
GM was created from the modulated spatially normal-
ized segmented GM images using the Template-O-Matic
(TOM8) toolbox [32]. Next, the custom priors were af-
fine-registered to the standard Montreal Neurological
Institute (MNI) space.
Voxel-based morphometry (VBM) preprocessing steps
were performed using the VBM8 toolbox for SPM8
(http://dbm.neuro.uni-jena.de/vbm/) and this involved
segmentation of MR images into GM tissue segments
using the standard unified segmented and non-linearly
warping of the tissue segments to the GM study-specific
customized template model [33]. Images were then
modulated to ensure that relative volumes of GM were
preserved following the spatial normalization procedure.
Sample homogeneity was checked to identify any out-
liers in the study population. Data for one participant in
the BC group were excluded from the analysis because
of a covariance below 2 SD and confirmation of visual
motion artifact.
ROI extraction
There are different nodal definition methods in brain
network analysis. While the results might be affected by
the choice of parcellation scheme, recent evidence
showed that the results of between-group comparison
remain intact regardless of the applied parcellation
scheme [34]. We generated 90 cortical and subcortical
regions of interest (ROIs), excluding the cerebellum,
from the Automated Anatomical Labeling (AAL) atlas
using the WFU PickAtlas Toolbox [35]. The ROIs were
identical to those used in a previous graph analysis study
of typical brain development by Fan and colleagues [22].
These AAL ROIs were resliced to the same dimensionas that of tissue segmented images obtained from the
VBM preprocessing step. The ROIs were subsequently
used to mask the individual modulated, normalized GM
images and extract the average volume within each ROI
using the REX toolbox (http://web.mit.edu/swg/software.
htm). A linear regression analysis was performed at
every ROI to remove the effects of age and total brain
volume. The residuals of this regression were then sub-
stituted for the raw ROI volume values [22,27,36].
Construction of structural correlation network
The extracted residual volumes of all 90 anatomical
ROIs were used for construction of structural correlation
networks. For each group, a 90 × 90 association matrix R
was generated with each entry rij defined as the Pearson
correlation coefficient between residual volumes of
regions i and j, across subjects. From each association
matrix, a binary adjacency matrix A was derived where
aij was considered 1 if rij was greater than a specific
threshold and zero otherwise. The diagonal elements of
the constructed association matrix were also set to zero.
The resultant adjacency matrix represented a binary un-
directed graph G in which regions i and j were con-
nected if gij was unity. Therefore, a graph was
constructed with N= 90 nodes (anatomical ROIs), with a
network degree of E equal to number of edges (links),
and a network density (cost) of D= E/[(N x (N-1))/2]
representing the fraction of present connections to all
possible connections. Since thresholding the association
matrices of different groups at an absolute threshold
results in networks with a different number of nodes
(and degrees) that might influence the network measures
and reduce interpretation of between group results [37],
two approaches were implemented for thresholding the
constructed association matrices based on previous stud-
ies [26-28]: (1) Thresholding the constructed association
matrices at a minimum network density in which all
nodes become fully connected in the brain networks of
both groups; (2) Thresholding the constructed associ-
ation matrices at a range of network densities and com-
paring the network topologies across that range.
Network analysis
Small-worldness The small-worldness of a complex
network, as described above, has two key metrics: the
clustering coefficient C and the characteristic path
length L of the network. The clustering coefficient of a
node is a measure of the number of edges that exist be-
tween its nearest neighbors. The clustering coefficient of
a network is thus the average of clustering coefficients
across nodes and is a measure of network segregation.
The characteristic path length of a network is the aver-
age shortest path length between all pairs of nodes in
Hosseini et al. BMC Neurology 2012, 12:28 Page 4 of 11
http://www.biomedcentral.com/1471-2377/12/28the network and is the most commonly used measure of
network integration [38]. To evaluate the topology of
the brain network, these parameters must be compared
to the corresponding mean values of a random graph
with the same number of nodes, total edges, and degree
distribution as the network of interest [39,40]. Thus, we
obtained the small-worldness index of a network as
[C/Crand]/[L/Lrand] where Crand and Lrand are the mean
clustering coefficient and the characteristic path length
of the random network [20]. In a small-world network,
the clustering coefficient is significantly higher than that
of random networks (C/Crand ratio greater than 1) while
the characteristic path length is comparable to random
networks (L/Lrand ratio close to 1).
Regional network measures We also investigated the
nodal characteristics of the constructed structural net-
works to identify differences in regional network mea-
sures between groups. Nodal betweenness centrality and
nodal degree were calculated for each of the anatomical
ROIs for the networks thresholded at minimum density
with full-connectivity. Nodal betweenness centrality is
defined as the fraction of all shortest paths in the net-
work that pass through a given node and is used to de-
tect important anatomical or functional connections.
Nodes that bridge disparate parts of the network have a
high betweenness centrality [38]. On the other hand,
nodal degree is defined as the number of connections
that a node has with the rest of the network and is con-
sidered a measure of interaction of a node, structurally
or functionally, with the network.
Network hubs Hubs are crucial components for effi-
cient communication in a network. Hubs are not only
considered as important regulators of information flow
but also play a key role in network resilience to insult
[38]. We considered a node as a hub if its betweenness
centrality was at least 2SD higher than mean network
centrality [26].
Comparing correlation strengths between groups To
test the significance of differences in overall inter-
regional correlation of gray matter volume between net-
works, the correlation coefficients were converted to z
values using Fisher’s r-to-z transform. This transform-
ation resulted in values that were approximately normally
distributed [28]. Then, a two sample t-test was used to
test the significance of the difference in mean overall cor-
relation between groups.
Comparing network measures between groups In
order to test the statistical significance of the between-
group differences in network topology and regional net-
work measures, a non-parametric permutation test with1000 repetitions was used [26,28]. In each repetition,
the calculated residual volumes of each participant were
randomly reassigned to one of the two groups so that
each randomized group had the same number of sub-
jects as the original groups. Then, an association matrix
was obtained for each randomized group. The binary
adjacency matrices were then estimated by thresholding
the association matrices at a range of network densities.
The network measures were then calculated for all
the networks at each density. The differences in net-
work measures between randomized groups were
then calculated resulting in a permutation distribu-
tion of difference under the null hypothesis. The ac-
tual between-group difference in network measures
was then placed in the corresponding permutation
distribution and a two-tailed p-value was calculated
based on its percentile position [27].
We used the Brain Connectivity Toolbox [38] for
quantification of network measures in addition to in-
house software, Graph Analysis Toolbox (http://nnl.
stanford.edu/Tools.html), for comparing the structural
networks. Brain Net Viewer (http://www.nitrc.org/
projects/bnv/) was used for visualization of the
graphs.
It should be noted that we could not statistically ex-
plore the relationship between cognitive-behavioral mea-
sures and the extracted network properties. It is because
the extracted network measures are group-specific and
can not be quantified for individuals. Therefore, we
could not perform statistical analysis (e.g. correlation
analysis) to relate network properties and cognitive-
behavioral outcomes.
Results
Comparing networks at minimum density
with full-connectivity
The minimum network density in which all nodes be-
came fully connected in the structural networks of both
groups was 0.184. The association matrices for each
group and corresponding binary adjacency matrices
thresholded at the minimum density are shown in
Figure 1. The correlation network of the BC group
showed lower overall correlation strength than the CON
group (t = 5.9, P <0.001). Topological measures for the
networks of both groups thresholded at the density of
0.184 are given in Table 2. In both groups, the normal-
ized characteristic path length of the network was close
to 1 and the normalized clustering coefficient was
greater than 1 which results in a small-worldness par-
ameter of greater than 1. Thus, consistent with previous
studies, the gray-matter correlation network of both
groups followed a small-world property. While no sig-
nificant difference in characteristic path length was
observed between networks (P= 0.22), the normalized
Figure 1 Association and binary adjacency matrices; association matrices for (A) BC and (B) CON groups, binary adjacency matrices for
(C) BC and (D) CON groups (connected regions are shown in red). The association matrices show the highest connectivity between regions
of interest as well as for inter-hemispheric regions.
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network (P< 0.05). Consequently, the small-worldness
parameter was found to be greater in the CON network
than in the BC network and the observed difference was
marginally significant (P= 0.08).Table 2 Network measures at minimum density of 0.184
with full connectivity
BC CON p-value
Density 0.184 0.184 —
Mean clustering coefficient 0.485 0.517 0.16
Characteristic path length 2.11 2.2 0.23
Normalized clustering 2.65 3.06 0.03
Normalized path length 1.15 1.20 0.22
Small-worldness 2.30 2.54 0.08Comparing networks across a range of density
In order to investigate changes in the network topology
as a function of network density (cost), we thresholded
the constructed association matrices at a range of net-
work densities. Changes in network parameters are
depicted in Figure 2. The figures show that both net-
works follow a small-world organization across the
range of densities. The results of comparison of the
two networks as a function of network density are
shown in Figure 3. While there was no significant dif-
ference in network characteristic path lengths between
groups (same level of integration), the clustering coef-
ficient was significantly higher (more segregated net-
work) in the CON network in various densities
resulting in higher small-worldness compared to the
BC group across a range of densities.
Figure 2 Global network measures; A) clustering coefficient, B)
characteristic path length and C) small-worldness of BC and
CON networks. The figures show that both networks follow a
small-world organization across the range of densities; the characteristic
path length is close to 1 (for the fully connected network, i.e.
density> 0.19) and the clustering is greater than 1 in different densities.
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(0.184), the BC network fragments sooner that the CON
network and thus the normalized path length of the BC
network increases relatively faster compared with that of
CON network. This results in a relatively large drop in
the difference in normalized path length between groups
in densities below 0.184.
Regional network measures
As shown in Figure 4, the CON group demonstrated
higher nodal betweeness/degree in several frontal and
temporal regions. The BC group demonstrated higher
nodal betweeness/degree primarily in parieto-occipital
regions but also in the anterior cingulate and left
thalamus.
Network hubs
In the BC group, network hubs were identified at left an-
terior cingulate, right inferior parietal lobule, and right
supramarginal gyrus. In CON group, hubs were found in
right middle frontal gyrus, left superior frontal gyrus,
right insula, right precuneus, and left middle temporal
gyrus (Figure 5).
Discussion
We applied graph theoretical analyses to compare gray
matter volume correlation networks of female primary
breast cancer (BC) survivors treated with chemotherapy
and female healthy controls (CON). We found an alter-
ation in small-world characteristics of the brain struc-
tural network in the BC group; an observation that
confirms our hypothesis suggesting changes in large-
scale brain network properties in BC survivors treated
with chemotherapy. To our knowledge, this is the first
report of altered large-scale network properties asso-
ciated with BC and chemotherapy.
Between-group differences in network topology
While the structural correlation networks of both groups
followed a small-world organization, the results revealed
a decrease in the small-world index of the BC group
compared to controls. The characteristic path lengths of
the BC and CON group networks were not different
whereas the clustering coefficient was significantly smal-
ler in the BC network than in the CON network.
Decreased clustering coefficient and small-world index
in the BC group was observed not only at the minimum
network density but also over a range of density
thresholds.
These findings suggest that the structural correlation
networks of BC patients tend to have a more rando-
mized configuration compared to CON group associated
with weaker regional connectivity and disrupted global
organization [38]. Given that BC tends to be a disease
Figure 3
Figure 3 Between-group differences in global network
measures; between-group differences in A) clustering
coefficient, B) characteristic path length and C) small-worldness
parameter. The vertical arrows represent the densities where the
difference is statistically significant at P< 0.05. It shows that while
there is no significant difference in network characteristic path
lengths between groups (same level of integration), the clustering
coefficient is significantly higher (more segregated network) in the
CON network in various densities resulting in higher small-worldness
compared to the BC group across a range of densities. Squares
represent control minus BC group measure, dashed lines show the
95% confidence interval and the dotted line shows the mean for the
random graph distribution.
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make women with BC more vulnerable to age-related
cognitive decline. Recent studies suggest that older BC
patients show increased chemotherapy-related cognitive
deficits [4,5]. Additionally, this same profile of networktopology (i.e. decreased clustering and small-world
index) has been associated with Alzheimer’s dementia
[41]. The interface between aging, breast cancer and
cognitive decline will be a critical area of continued
investigation.
The observed lack of densely interconnected neighbors
in the network of BC group is also supported by the
lower overall correlation strength in the association
matrix of BC group compared to CON group. Together,
the results of network-level analysis corroborates previ-
ous structural neuroimaging findings that have demon-
strated a diffuse pattern of atrophy in gray matter
volumes in BC patients [15,16] and further suggests an
alteration in the coordinated patterns of brain morph-
ology in the structural network of these patients.
One potential mechanism underlying this network-
level alteration is white matter damage. There is a large
body of evidence suggesting that global gray matter atrophy
is associated with focal and global white matter damage
due in part to the transection of axons and subsequent
retrograde neuronal loss [42,43]. Animal studies show that
chemotherapy suppresses neural progenitor cell prolifera-
tion responsible for white-matter tract integrity and
cortico-cortical connections [44-48]. Thus, the observed
network-level alteration in structural correlation network
of BC patients might arise from neurotoxic effects of
chemotherapy on cortico-cortical connections. This idea
is also supported by a recent diffusion weighted imaging
study involving chemotherapy-treated BC survivors that
reported a diffuse pattern of microstructural white matter
damage [14].Between-group differences in regional network measures
High degree/betweenness nodes were observed mainly
in frontotemporal regions in the CON network and in
parietal, cingulate, and occipital regions in the BC net-
work. Nodes with high degree/centrality in the structural
network identify regions that are highly interactive and
have the potential to participate in a large number of
functional interactions [49]. The results indicate that the
Figure 4 Difference in regional network characteristics relative to random networks; A) Controls showed greater network betweenness
centrality in left SFG, left PrCG, right PCUN, right REC and right ITG while the BC group showed greater betweenness in right ANG,
right CALC, left ACC, right IPL, and left THL. B) Controls demonstrated higher network degree in left MFG, left MFOr, bilateral SFG, left
PrCG, right ITG and right MTG. The BC group showed greater degree in bilateral ANG, left IOG, right IPL and left SMG. Squares represent control
minus BC group measure, dashed lines show the 95% confidence interval and the dotted line shows the mean for the random graph distribution.
Regions that showed significantly higher/lower degree in CON relative to BC are shown in pink/cian color on the ICBM152 brain template.
Abbreviations are used as follow: L: left hemisphere; AMYG: amygdala; ANG: angular gyrus; CALC: calcarine fissure; CN: caudate nucleus; ACC:
anterior cingulate; MCC: mid-cingulate; PCC: posterior cingulate; CUN: cuneus; IFOp: inferior frontal gyrus, opercular part; IFOr: inferior frontal gyrus,
orbital part; IFTr: inferior frontal gyrus, triangular part; MedFOr: medial frontal gyrus, orbital part; MFG: middle frontal gyrus; MFOr: middle frontal
gyrus, orbital part; SFG: superior frontal gyrus; MedSF: superior frontal gyrus, medial part; SFOr: superior frontal gyrus, orbital part; FG: fusiform
gyrus; HSHL: heschl gyrus; HIPP: hippocampus; INS: insula; LNG: lingual gyrus; IOG: inferior occipital gyrus; MOG: middle occipital gyrus; SOG:
superior occipital gyrus; OFB: olfactory cortex; PLD: lenticular nucleus, pallidum; PCL: paracentral lobule; PHIP: parahippocampal gyrus; IPL: inferior
parietal lobule; SPL: superior parietal lobule; PoCG: postcentral gyrus; PrCG: precentral gyrus; PCUN: precuneus; PUT: putamen; REC: gyrus rectus;
RLN: rolandic operculum; SMA: supplementary motor area; SMG: supramarginal gyrus; ITG: inferior temporal gyrus; MTG: middle temporal gyrus;
MTP: middle temporal pole; STP: superior temporal pole; STG: superior temporal gyrus; THL: thalamus.
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the frontotemporal regions.
Reduction in gray and white matter volumes in fronto-
temporal regions of patients with BC before and after
treatment has been shown in a recent study [15]. A
number of functional neuroimaging studies have alsoreported increased activation in the frontotemporal net-
work in these patients suggesting necessity of recruiting
a compensatory neural mechanism to complete certain
tasks, or decreased efficiency of these systems [10,50,51].
The observed changes in the centrality of the frontotem-
poral nodes in the network of BC patients is consistent
Figure 5 Network hubs; structural correlation networks and hubs overlaid on ICBM152 brain template for A) BC and B) CON groups.
Grey lines indicate connections and spheres represent regions. The radius of the spheres is proportional to the nodal betweenness. Hubs are
shown in green color.
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ment of these patients in memory and executive
functioning.
There are several mechanisms that could explain the
observed change in the distribution of highly influential
nodes in BC group with less highly-interactive nodes in
the prefrontal and temporal cortices. Certain genetic and
immunologic factors have been proposed as important
contributors to cognitive decline in patients with BC [3].
For example, apolipoprotein E (APOE) is a complex pro-
tein that has an important role in neuronal repair and
plasticity after injury [52]. The relationship between this
genotype and adverse cognitive performance and reduce
mesial temporal (hippocampal) volume has been shown
in long-term survivors of BC [53]. Also, cytokines that
become dysregulated during cancer and/or chemother-
apy treatment have been shown to affect cognitive func-
tion in healthy adults [54]. Cytokines have important
roles in central nervous system functioning including
modulation of dopamine and other neurotransmitters
[55] that affect the frontotemporal network [56]. The
effects of genotypic variations and cytokine regulation
on large-scale networks have not been established and
require further investigation.
The BC group had significantly more post-menopausal
women than the healthy comparison group. This isexpected given that chemotherapy frequently causes
early menopause [57] and tamoxifen can increase meno-
pausal symptoms [19], both by blocking or reducing es-
trogen. Estrogen has a marked effect on brain function,
particularly in frontotemporal regions and their con-
comitant executive and memory functions [58]. Previous
studies suggest that tamoxifen, in addition to chemo-
therapy, can have detrimental effects on cognitive and
neurobiologic outcomes in BC survivors [59,60]. The
present findings may indicate potential secondary neu-
roendocrine effects on large-scale brain networks.
Network hub analysis
There was a difference in the number and distribution
of hubs between the BC and CON groups. We found six
network hubs in the CON group mainly across frontal
and temporal regions compared to three hubs in the BC
group primarily in parietal and cingulate areas. The
identified hubs in the CON group are consistent with
the results of previous graph-theoretical analysis involv-
ing healthy adults [26,28]. The present findings indicate
that the network of BC patients does not show expected
prefrontal and temporal hubs suggesting network altera-
tions involving these regions, again which are critical for
the executive function and memory skills commonly dis-
rupted in BC.
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network was half the number of hubs in the CON net-
work. Since hubs are crucial components for efficient
communication across the network, this observation
suggests a less efficient information transfer in the net-
work of BC patients. These results are consistent with
our previous findings showing that BC survivors can
often perform similarly to controls on cognitive tasks
but require significantly more neural resources to do so
[50]. Standardized neurocognitive tests may lack sensi-
tivity to these subtle changes [2] as most were designed
to assess specific cognitive skills. Based on the present
findings, measures of reaction time or parallel processing
should be included in evaluations of BC-related cogni-
tive outcome. Quantitative process measures might also
be more effective as these assessments examine the effi-
ciency of the patient’s performance strategies in addition
to performance accuracy [61].
This study has several limitations. First, this was a
cross-sectional study and therefore, we could not dir-
ectly test the dissociated effects of cancer and chemo-
therapy on network measures. Future studies can
address this issue through longitudinal evaluations of
network measures in patients with BC. In addition, fu-
ture studies might investigate whether the alteration in
gray matter network is due to any cancer (and not just
breast cancer). It is also important to dissociate between
cancer-related physiological changes and cancer effects
on mental states. Second, the network measures were
identified by calculating the correlations of gray matter
volume across subjects. While this methodology is com-
mon for investigating between-group differences in brain
structural network, it lacks the ability to explore the in-
dividual differences in network parameters. Specifically,
we could not explore the effect of treatment period, regi-
men, age or other individual differences on network
parameters or investigate the effects of altered network
parameters on cognitive-behavioral outcome.Conclusions
Despite these limitations, these findings increase our
understanding of BC and chemotherapy-related cogni-
tive impairment by demonstrating alterations in specific
network properties. Survivors of BC treated with chemo-
therapy showed decreased regional connectivity (cluster-
ing coefficient) and global network organization (small-
worldness) and integration (hubs) suggesting reduced
robustness and efficiency of the network. A pattern of
frontotemporal abnormality was also noted. These
results contribute novel insights regarding the neurobio-
logic mechanisms underlying cognitive deficits in these
patients and highlight critical areas for future research
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